Global Morinda Officinalis Extract Market

The Global Morinda Officinalis Extract Market was valued at USD 25 million in 2023 and is projected to reach USD 52.53 million by 2032, exhibiting a Compound Annual Growth Rate (CAGR) of 8.60% during the forecast period (2025–2034). This growth is driven by rising demand for natural health products, increasing awareness of traditional Chinese medicine, and expanding applications in pharmaceutical and nutraceutical sectors.

As the herbal extract industry evolves toward higher quality standards and diversified applications, the spotlight is on the key players who are driving innovation, market expansion, and sustainability. In this blog, we profile the Top 10 Companies in the Morinda Officinalis Extract Market—a mix of established manufacturers and emerging innovators shaping the future of global herbal therapeutics.

---

Morinda Officinalis Extract Market – View in Detailed Research Report

Market Size & Growth Outlook

The global market for Morinda Officinalis Extract was estimated at USD 25 million in 2023. By 2034, the market is projected to reach USD 52.53 million, reflecting a robust CAGR of 8.60% over the forecast period. North America is expected to contribute USD 7.51 million in 2023 with a CAGR of 7.37% from 2025 to 2034.

Product Definition

Morinda officinalis extract, also known as Radix Morindae officinalis extract, is derived from the roots of the Morinda officinalis plant—a medicinal herb native to China. The extract is obtained by processing and concentrating the active compounds found in the plant’s roots, and is widely used in traditional medicine, health supplements, and functional foods.

Top 10 Company Ranking

---

10️⃣ 1. Shaanxi Yongyuan Bio-Tech

Headquarters: Xi’an, China
Key Offering: High‑purity Morinda Officinalis Extract (10:1 & 20:1 ratios)

Shaanxi Yongyuan Bio-Tech has established itself as a leader in herbal extract manufacturing, focusing on stringent quality control and GMP compliance. The company supplies both raw extracts and finished products to pharmaceutical and nutraceutical firms worldwide.

Sustainability & Growth Initiatives:

• Investing in renewable energy for extraction facilities.
• Developing eco‑friendly extraction solvents to reduce environmental impact.
• Expanding product portfolio to include standardized extracts for clinical trials.

---

9️⃣ 2. Shangcheng Bio

Headquarters: Shanghai, China
Key Offering: 4:1 Extraction Ratio Morinda Officinalis Extract

Shangcheng Bio specializes in scalable production of Morinda Officinalis Extract, leveraging advanced chromatography techniques to ensure consistency and potency. The company partners with global health‑product manufacturers to supply high‑quality raw materials.

Sustainability & Growth Initiatives:

• Implementing zero‑waste processing protocols.
• Establishing a research partnership with a leading university for bioactive compound discovery.
• Targeting 15% market share in the Asian nutraceutical segment by 2030.

---

8️⃣ 3. Tianyuan Bio

Headquarters: Guangzhou, China
Key Offering: 10:1 Extraction Ratio Morinda Officinalis Extract

Tianyuan Bio focuses on large‑scale production and export of Morinda Officinalis Extract. The firm has secured multiple international certifications, enabling access to markets in Europe and North America.

Sustainability & Growth Initiatives:

• Adopting solar‑powered extraction units.
• Launching a proprietary “green” extraction line to reduce solvent usage.
• Expanding into functional food applications by 2028.

---

7️⃣ 4. Xian Ruilin

Headquarters: Xi’an, China
Key Offering: 20:1 Extraction Ratio Morinda Officinalis Extract

Xian Ruilin excels in high‑concentration extracts, catering to pharmaceutical research and specialty health products. The company’s R&D team works closely with clinical researchers to validate therapeutic claims.

Sustainability & Growth Initiatives:

• Investing in life‑cycle assessment for product sustainability.
• Collaborating with NGOs to promote sustainable sourcing of raw materials.
• Planning to launch a flagship product line for anti‑aging applications by 2027.

---

6️⃣ 5. Ningbo Tech‑Inno Health

Headquarters: Ningbo, China
Key Offering: Standardized Morinda Officinalis Extract for health supplements

Ningbo Tech‑Inno Health specializes in formulating extracts for dietary supplements, ensuring bioavailability and stability through advanced encapsulation technologies.

Sustainability & Growth Initiatives:

• Developing biodegradable packaging solutions.
• Partnering with local farmers for sustainable raw material sourcing.
• Targeting a 20% growth in the European supplement market by 2032.

---

5️⃣ 6. Xian Huilin Bio

Headquarters: Xi’an, China
Key Offering: 4:1 & 10:1 Extraction Ratio Morinda Officinalis Extract

Xian Huilin Bio combines traditional extraction methods with modern technology to deliver high‑quality extracts for both pharmaceutical and nutraceutical applications.

Sustainability & Growth Initiatives:

• Implementing water‑recycling systems in production.
• Launching a research consortium to explore new therapeutic uses.
• Expanding distribution to South America by 2029.

---

4️⃣ 7. Yunnan Baiyao Group

Headquarters: Kunming, China
Key Offering: Herbal extract blends including Morinda Officinalis

Yunnan Baiyao Group is a globally recognized name in traditional Chinese medicine, now expanding its portfolio to include high‑grade Morinda Officinalis Extract for use in health supplements and functional foods.

Sustainability & Growth Initiatives:

• Adopting carbon‑neutral production processes.
• Investing in community health programs to promote product awareness.
• Targeting a 30% increase in export sales by 2035.

---

3️⃣ 8. China National Pharmaceutical Group (CNPG)

Headquarters: Beijing, China
Key Offering: Pharmaceutical‑grade Morinda Officinalis Extract

CNPG leverages its extensive distribution network to supply Morinda Officinalis Extract to hospitals and pharmaceutical manufacturers across China and abroad.

Sustainability & Growth Initiatives:

• Implementing ISO 14001 environmental management.
• Expanding research into anti‑inflammatory applications.
• Planning a joint venture with a US biotech firm by 2028.

---

2️⃣ 9. Jiangsu Hengrui Pharmaceutical

Headquarters: Suzhou, China
Key Offering: Novel drug formulations using Morinda Officinalis Extract

Jiangsu Hengrui Pharmaceutical focuses on integrating Morinda Officinalis Extract into innovative drug delivery systems, targeting chronic disease management.

Sustainability & Growth Initiatives:

• Investing in green chemistry for extraction.
• Collaborating with global research institutions.
• Achieving a 25% market share in the Asia‑Pacific nutraceutical sector by 2034.

---

1️⃣ 10. Zhejiang Hisun Pharmaceutical

Headquarters: Hangzhou, China
Key Offering: High‑purity Morinda Officinalis Extract for dietary supplements

Zhejiang Hisun Pharmaceutical combines traditional extraction expertise with modern quality assurance to deliver premium extracts for health‑food markets.

Sustainability & Growth Initiatives:

• Implementing renewable energy across all plants.
• Launching a certification program for sustainable sourcing.
• Targeting expansion into the EU market by 2032.

---

Download FREE Sample Report: Morinda Officinalis Extract Market – View in Detailed Research Report

Get Full Report: Morinda Officinalis Extract Market – View in Detailed Research Report

---

Outlook: The Future of Morinda Officinalis Extract

The Morinda Officinalis Extract market is poised for significant expansion, driven by increasing consumer preference for natural health solutions and the growing integration of traditional Chinese medicine into mainstream healthcare. The market is expected to shift toward higher‑purity extracts, advanced delivery systems, and diversified applications in pharmaceuticals, nutraceuticals, and functional foods.

Key Trends Shaping the Market

• Expansion of high‑purity extraction technologies to meet stringent regulatory standards.
• Growing demand for standardized extracts in clinical research and drug development.
• Increasing collaboration between herbal extract manufacturers and biotech firms.
• Adoption of sustainable sourcing and eco‑friendly production practices.
• Emergence of new applications in anti‑aging, immunity support, and chronic disease management.

Companies that invest in research, quality assurance, and sustainable practices will be best positioned to capture the growing market share in the coming decade.